A GLANCE ON PHARMACOGENOMICS BASIS ON GENETIC DISORDERS AND ADVANCES IN RECOMBINANT-DNA TECHNOLOGY AS A NEW APPROACH

Journal Title: Mintage journal of pharmaceutical and medical sciences - Year 2018, Vol 7, Issue 7

Abstract

Background: Advent of r-DNA techniques and their application to biology and healthcare system is one of the most exciting eras of scientific history. Objectives: In this review, we discuss about pharmacogenetics, pharmacogenomics, advances, applications, challenges and future perspectives of r-DNA technology. Variability in drug responses is the net result of multiple interacting genes and environmental factors. Conclusion: We found that many technical and conceptual barriers still remain unveil to the world, if the true potential of this field recognize, the genetic disorders will completely disappear and will get a solution for most questionable microbial resistance. It is anticipated that less than 10% of drugs in 10 years from now will be prescribed following a pharmacogenetic test. In future, we need more intensive studies in the areas of pharmacogenomics to identify the targeted gene which is responsible for specific diseases or variable drug response, so the r-DNA technology can easily develop a new drug molecule which can change the gene expression or may modify the targeted gene. Field of pharmacogenomics will lead to new important insights and discoveries that will ultimately lead to the development of new and better drugs and to the rational use of drugs that are already on the market.

Authors and Affiliations

Dr. Krishna Ravi, Sudha M, Dr. Venkateswarmurthy, Dr. Sambathkumar R

Keywords

Related Articles

MOLECULAR INTERACTION OF NATURAL BIFLAVONOIDS, AS COMPETITIVE ANTAGONISTS, WITH AROMATASE RELATED TO BREAST CANCER: AN IN SILICO APPROACH

Objective: Understanding the mechanism of inhibition exerted on aromatase by natural compounds is essential since such compounds may be helpful as a source of efficacious therapeutic agents for the management of postmeno...

ALTERATIONS IN BMI, BLOOD PRESSURE EXERCISE WITH ONE TO THREE TIMES PER WEEK WITH SOMEONE WHO DO NOT EXERCISE IN STUDENTS OF TEHRAN MEDICAL BRANCH OF AZAD UNIVERSITY, 2011

Background and Aim: These days, no one can dispute the fact that, in addition to positively affecting physical health, exercising also has the same effect on people’s mental health. Given that young male and female unive...

DISTRIBUTION OF ABO AND RH BLOOD GROUPS IN THE ORIENTAL REGION OF MOROCCO

Objective: The aim of this study is to determine the distribution of phenotypic and allelic frequencies of blood groups ABO and RH in the provinces of the Oriental region of Morocco. Methodology: ABO and RH grouping were...

WATER MEDIATED DIELS-ALDER [4+2] CYCLOADDITION REACTION: A GREEN CHEMICAL APPROACH FOR THE SYNTHESIS OF SOME 2-(6-METHOXY-2-NAPHTHYL)-3-(SUBSTITUTED PHENYL) BICYCLO [2.2.1] HEPTA-5-ENE-2-ONES AND EVALUATION OF BIOLOGICAL ACTIVITIES

Objective: To synthesis some 2-(6-methoxy-2-naphthyl)-3-(substituted phenyl) bicyclo[2.2.1] hepta-5-ene ketones and evaluation of their biological activities. Methods: Green chemical approach of water mediated fly-ash...

ANTI OXIDANT ACTIVITY OF SYZYGIUM CUMINI L. LEAVES: EFFECT OF EXTRACTION SOLVENTS

Aim: Toxicity of synthetic anti-oxidants is a matter of concern. Therefore, search for natural anti-oxidant was continuously going on and even extended to the field of medicinal plants. Syzygium cumini Linn (S. cumini L...

Download PDF file
  • EP ID EP537102
  • DOI -
  • Views 147
  • Downloads 0

How To Cite

Dr. Krishna Ravi, Sudha M, Dr. Venkateswarmurthy, Dr. Sambathkumar R (2018). A GLANCE ON PHARMACOGENOMICS BASIS ON GENETIC DISORDERS AND ADVANCES IN RECOMBINANT-DNA TECHNOLOGY AS A NEW APPROACH. Mintage journal of pharmaceutical and medical sciences, 7(7), 1-6. https://europub.co.uk/articles/-A-537102